Repurposing Drugs in Oncology (Re-DO) redoproject.org

ГЛАВА 11

Baker, S. G., Cappuccio, A., & Potter, J. D. (2010). Research on early-stage carcinogenesis: are we approaching paradigm instability? Journal of Clinical Oncology 28: 3215–3218 doi:10.1200/JCO.2010.28.5460

Maley, C., Aktipis, A., Graham, T. et al. (2017) Classifying the evolutionary and ecological features of neoplasms, Nat Rev Cancer 17: 605–619 doi:10.1038/nrc.2017.69

Helmneh, M. Sineshaw, H.M, Jemal, A., Ng, K. et al. (2019) Treatment patterns among de novo metastatic cancer patients who died within 1 month of diagnosis, JNCI Cancer Spectrum 3: pkz021 doi:10.1093/jncics/pkz021

Ambroggi, M., Biasini, C., Toscani, I. et al. (2018). Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature, Supportive Care in Cancer 26: 2945–2953 doi:10.1007/s00520–018–4184–3

Weeks, J.C., Catalano, P.J., Cronin, A. et al (2012) Patients' expectations about effects of chemotherapy for advanced cancer, N Engl J Med 367: 1616–1625 doi:10.1056/ NEJMoa1204410

Dobzhansky, T. (1973) Nothing in biology makes sense except in the light of evolution, The American Biology Teacher 35: 125–129 doi:10.2307/4444260

Berenblum, I. (1974) Carcinogenesis as a biological problem. Frontiers of Biology, 34, Chapter 5.6, p317

McCarthy, M. (2006) New science inspires FDA commissioner Andrew von Eschenbach, The Lancet 367: 1649 doi:10.1016/ S0140–6736(06)68718–7